CURRENT NEWS

• 30.10.2020
  FDA Resource Reallocation Impacts DiviTumTKa Timeline
• 30.10.2020
  White's New Drug Seizes the New Crown Business Opportunity and Will Launch a Multinational Clinical Trial
• 29.10.2020
  Equillium Receives FDA Clearance of COVID-19 IND for Phase 3 Trial
• 29.10.2020
  BioTelemetry, Inc. Reports Third Quarter 2020 Financial Results
• 29.10.2020
  UCLA Begins Recruitment for Phase 3 of the Oxford University - AstraZeneca COVID-19 Vaccine Trial
• 29.10.2020
  AbCellera and Kodiak Sciences Enter Second Antibody Discovery Collaboration for Ophthalmology Targets
• 29.10.2020
  Innocoll Announces Commercial Launch of XARACOLL (Bupivacaine HCI) Implant, a Non-Opioid, Drug-Device Treatment Option for Acute Postsurgical Pain Relief for Up to 24 Hours Following Open Inguinal Hernia Repair in Adults
• 29.10.2020
  OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of Its CORVax12 Vaccine Candidate for COVID-19
• 29.10.2020
  Oregon Health & Science University Joins Multicenter Covid-19 Bva-100 Study
• 29.10.2020
  Genprex Receives Conditional FDA Acceptance of Proprietary Name REQORSA for Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer
• 29.10.2020
  Kintor Pharmaceutical's COVID-19 Clinical Trials for Proxalutamide to Expand Patient Enrolment
• 29.10.2020
  Teleflex Announces Quarterly Dividend
• 29.10.2020
  Inivata Announces Collaboration With Maverick Therapeutics for Use of RaDaR Assay
• 29.10.2020
  aTyr Pharma Announces Research Collaboration With Medical University of South Carolina
• 29.10.2020
  Angle PLC Announces Interim Results
• 29.10.2020
  Tergus Pharma and Phenom Pharmaceuticals Collaborate to Develop Novel Delivery System for SARS-CoV-2 Anti-Binding Agent
• 29.10.2020
  'Ad Promising $8,830 for AZ's Covid-19 Trial Participant Is a Hoax'
• 29.10.2020
  Humanigen Announces First Patient Dosed in NIH ACTIV-5/Big Effect Trial Evaluating Lenzilumab for COVID-19
• 29.10.2020
  Charles River Laboratories Announces Third-Quarter 2020 Results
• 29.10.2020
  Emulate Signs Collaborative Agreement With the FDA to Apply Lung-Chip to Evaluate Safety of COVID-19 Vaccines and Protective Immunity Against SARS-CoV-2

Records per page:

Page

Total: 22650 records.